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The prevalence of Mycoplasma genitalium is high in vulnerable populations of women in low-resource settings. However, the
epidemiology of infection in these populations is not well established. To determine the prevalence of Mycoplasma genitalium
and its association with cervical cytology and other correlates, we recruited 350 female sex workers (FSW) who were 18 to 50
years old in Nairobi, Kenya, for a cross-sectional study. A questionnaire was administered at baseline to obtain information on
sociodemographics and sexual behaviors. Women underwent a pelvic exam, during which a physician collected cervical-exfolia-
tion samples for conventional cytology and sexually transmitted infection (STI) testing. Samples were tested for M. genitalium
and other STI organisms (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) and the E6/E7 mRNA of hu-
man papillomavirus (HPV) by Aptima nucleic amplification assays. The prevalence of M. genitalium was 12.9%. FSW who en-
gaged in sexual intercourse during menses were less likely to have M. genitalium infection than those who did not (odds ratio
[OR], 0.3; 95% confidence interval [95% CI], 0.1, 0.9). M. genitalium was also less prevalent among FSW who had worked in
prostitution for >5 years (6.2%) than among those who had worked for <3 years (17.6%) (OR, 0.3; 95% CI, 0.1, 0.8). FSW who
reported more frequent condom use were more likely to be infected with M. genitalium than those who reported less frequent
use (OR, 3.8; 95% CI, 1.2, 11.6). These correlates differ from those found in M. genitalium studies conducted with FSW from
West Africa and China. Further longitudinal analyses assessing associations with persistent M. genitalium infection are needed.
Mycoplasma genitalium is an emergent bacterium that is trans-mitted via sexual activity and has been associated with com-
plications in the female genital tract, including endometritis, tub-
al-factor infertility, pelvic inflammatory disease (PID), cervicitis,
and ectopic pregnancy (1–9). M. genitalium may also increase the
risk of HIV transmission and associated shedding (10–13).
Vulnerable populations of women in low-resource settings
have a higher-than-average susceptibility to sexually transmitted
infections (STIs) and subsequent complications of the reproduc-
tive tract, including those caused by M. genitalium, Chlamydia
trachomatis, and Neisseria gonorrhoeae (14). In the case of female
sex workers (FSWs), STI risk is increased due to a greater exposure
to unsafe sexual behaviors, such as unprotected sexual intercourse
and high numbers of clients/sexual partners (15).
The prevalence and associated risk factors for M. genitalium
have been investigated both in the general population and among
populations at high risk for STIs in sub-Saharan Africa, Asia, the
United Kingdom, and the United States (4, 16–23). Across many
of these studies, a young age, little education, single marital status,
and high numbers of sex partners remained consistently associ-
ated with infection (4, 9, 16, 18, 21, 23, 24). Findings are less
consistent among the few studies that examined risk factors
among FSWs. In the literature, studies have shown similar associ-
ations of M. genitalium infection with basic demographic factors,
such as education and marital status. However, there is less agree-
ment for sexual-behavioral and clinical correlates, such as con-
dom use, duration of sex work, and history of STIs (16, 18, 23).
Chinese sex workers who did not present STI symptoms in the
year prior to the study were more likely to have infection with M.
genitalium than those who did (23). In contrast, a study conducted
in sub-Saharan Africa found that sex workers who presented clin-
ical symptoms were more likely to have M. genitalium infection
than those who were asymptomatic (18).
In studies examining concurrent M. genitalium infection with
other STIs in the general population, M. genitalium was found to
be associated with urethritis, cervicitis, and PID (25–28). How-
ever, more-recent research indicates the role of M. genitalium in
nonchlamydial nongonococcal urethritis (NCNGU), supporting
its independent role as an etiological factor for NCNGU and other
urogenital complications (29, 30). While the role of human pap-
illomavirus (HPV) in the etiology of cervical cancer is well estab-
lished, evidence demonstrates a positive relationship between M.
genitalium and HPV infection as well as abnormal cervical cytol-
ogy (8, 31–34). M. genitalium was associated with a higher risk of
HPV among Japanese men with urethritis, with both organisms
present in the urethral tract (33). Among a cohort of FSWs, M.
genitalium was positively associated with the prevalence of high-
risk HPV (hrHPV) (32). An in vitro study of human cells infected
with four urogenital mycoplasmas found that M. genitalium in-
fection altered the gene expression of cervical epithelial cells, sup-
porting its potential role in cervical dysplasia and cervical cancer
progression (35). Infection with M. genitalium has also been pos-
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itively associated with cervical inflammation, a condition associ-
ated with high-risk cervical neoplasia (8, 9, 36, 37).
There are widespread implications of understanding the char-
acteristics of M. genitalium infection in populations susceptible to
STIs and related complications. Therefore, the objective of this
study was to determine the prevalence of M. genitalium infection,
identify correlates for infection, and explore the relationship be-
tween M. genitalium and cervical cytology in a cohort of FSWs in
Kenya.
MATERIALS AND METHODS
Study population. Ethical approval was granted by the Institutional Re-
view Boards (IRB) at Kenyatta National Hospital (Nairobi, Kenya) and
the University of North Carolina (Chapel Hill, NC, USA). From August
2009 to March 2011, FSWs attending the Korogocho clinic in Nairobi,
Kenya, were invited to participate in this study to determine the preva-
lence of correlates for M. genitalium infection. The clinic provided coun-
seling and medical care, including screening and treatment of cervical
cancer as well as of STIs for FSWs in the Korogocho slum area. Detailed
information on the study population and sample collection has been pre-
viously described (38). Briefly, a total of 350 FSWs aged 18 to 48 years
provided written informed consent and were subsequently enrolled from
among approximately 425 FSWs who were invited to participate in the
study. Each participating woman underwent a pelvic examination, where
the physician collected cervical specimens for cytology, histology, and STI
testing, including for M. genitalium and HPV infections.
M. genitalium and STI testing. Encoded, deidentified cervical sam-
ples were transported to Hologic Gen-Probe in San Diego, CA, for M.
genitalium DNA testing using the Aptima research-use-only assay (Ho-
logic Gen-Probe), which uses target capture, transcription-based ampli-
fication (TMA), and hybridization protection to capture, amplify, and
detect M. genitalium 16S rRNA (39). The specimens were also tested (i) for
Chlamydia trachomatis and Neisseria gonorrhoeae by the Aptima Combo 2
assay, (ii) for Trichomonas vaginalis by the Aptima TV assay, and (iii) for
HPV by the Aptima HPV assay, which qualitatively detects E6/E7 mRNA
of 14 hrHPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68)
(Hologic Gen-Probe, Inc., San Diego, CA). All assays utilized target cap-
ture, TMA, and hybridization principles similar to those used for M. geni-
talium detection.
Serum was tested for HIV antibodies by enzyme-linked immunosor-
bent assay (ELISA) (Detect HIV-1; Biochem ImmunoSystems, Inc., Mon-
treal, Canada), with positive results confirmed by a second ELISA. Periph-
eral blood CD4 cells were also enumerated. The HIV ELISA and CD4
assays were conducted at the University of Nairobi. All assays were per-
formed according to the manufacturer’s instructions, with the technicians
blind to cervical cytology, laboratory, and other study results.
Cervical cytology. The Pap smears were evaluated at the University of
Nairobi and classified according to the 2001 Bethesda System (40). All
smears were independently read by two cytopathologists blind to M. geni-
talium and all other study results. In cases of discordant diagnoses be-
tween the two cytology readings, the slides were reassessed a third time,
with the final diagnosis being the consensus of the opinions of the review-
ing cytopathologists. Study participants were notified of their cytology
results within 2 weeks after their screening visit. Women with low-grade
squamous intraepithelial lesions (LSIL) were instructed to undergo a re-
peat cytology 4 months later. Women with high-grade squamous intra-
epithelial lesions (HSIL) were immediately referred for a colposcopy and
biopsy. In cases of histological cervical intraepithelial neoplasia 2 (CIN-2)
or more-severe neoplasia (at least CIN-2), the women received standard
care and treatment at Kenyatta National Hospital.
Statistical analysis. Of the 350 FSWs recruited, 1 woman was missing
baseline questionnaire data and was excluded from analyses, resulting in a
final sample size of 349. Distributions of M. genitalium and other STIs
were assessed by univariate analyses. Odds ratios (ORs) and 95% confi-
dence intervals (CI) were calculated by unconditional logistic regression
to examine crude associations between baseline characteristics and M.
genitalium. The Wald test was utilized to determine the inclusion of vari-
ables for the multivariable logistic-regression model. Any correlate asso-
ciated with M. genitalium at a P of 0.15 were selected for the multivariable
model. Additionally, M. genitalium was reviewed as a correlate of cervical
cytology. Binary and categorical variables with a sample size of less than 10
in a stratum (N. gonorrhoeae, CD4 count) were eliminated from the re-
gression analyses when looking within strata of M. genitalium infection.
Analyses were performed using SAS version 9.2.
RESULTS
The median age of study participants was 28 years overall (range,
18 to 48 years). The median age at sexual debut was 16 years
(range, 10 to 25 years), and the average duration of prostitution
TABLE 1 Prevalence of Mycoplasma genitalium and other sexually transmitted infections among female sex workers in Kenya
Parameter









Overall % of subjects infected 12.9 3.7 2.3 7.2 24.0 29.5
Median age in yr (range) 26 (19–46) 23 (19–31) 26 (21–35) 30 (22–44) 32 (21–48) 32 (20–43)
% in age group (yr):
18–24 (n  89) 18.0 11.4 3.4 9.0 7.9 32.6
25–29 (n  108) 13.9 1.9 2.8 3.7 18.5 29.6
30–34 (n  72) 8.3 1.4 1.4 4.2 36.6 30.6
35 (n  80) 10.0 0.0 1.3 12.5 38.5 25.0
P trend 0.07 0.001 0.34 0.40 0.001 0.33
% with indicated duration of
prostitution (yr)
3 (n  74) 17.6 10.8 4.1 5.4 18.9 27.0
3–5 (n  145) 16.6 2.8 1.4 9.7 21.7 31.7
5 (n  130) 6.2 0.8 2.3 5.4 29.5 28.5
P trend 0.01 0.001 0.64 0.78 0.07 0.94
a HIV-1, human immunodeficiency virus type 1; hrHPV, high-risk human papillomavirus.
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was 5.5 years (Table 1). Most of the women had never been mar-
ried or were widowed, divorced, or separated and had completed
a primary school education (Table 2). Among the 349 FSW with
baseline sample data, the prevalences of M. genitalium, C. tracho-
matis, N. gonorrhoeae, and T. vaginalis infection were 12.9%,
3.7%, 2.3%, and 7.2%, respectively.
Trends of sexually transmitted infections by age. The median
age for women infected with M. genitalium was 26 years (range, 19
to 46 years) (Table 1). The prevalence of both M. genitalium and C.
trachomatis infection was higher among 18- to 24-year-olds than
TABLE 2 Sociodemographic, sexual-behavioral, and biological factors













18–24 89 18.0 1.0f
25–29 108 13.9 0.7 (0.3, 1.6)
30–34 72 8.3 0.4 (0.2, 1.1)
35 80 10.0 0.5 (0.2, 1.3)
Marital statusc




191 14.4 1.2 (0.6, 2.3)d
Educationc
Primary or less 265 13.6 1.0
Secondary or more 83 10.8 0.8 (0.4, 1.7)
Income/moc,e
4,000 Ksh 201 10.5 1.0f
4,000 Ksh 147 16.3 1.7 (0.9, 3.1)
Smoking status
Never 217 12.4 1.0
Past 46 17.4 0.9 (0.4, 2.0)
Yes, still 86 11.6 1.5 (0.6, 3.5)
Alcohol usec
No 57 10.5 1.0




Negative 291 12.0 1.0
Positive 83 17.2 1.2 (0.6, 2.4)
HPV RNA
Negative 246 11.4 1.0
Positive 103 16.5 1.5 (0.8, 3.0)
Chlamydia trachomatisc
Negative 335 12.8 1.0
Positive 13 7.7 0.6 (0.1, 4.5)
Trichomonas vaginalis
Negative 324 12.7 1.0
Positive 25 16.0 1.3 (0.4, 4.0)
Sexual-behavioral
characteristics
Avg charge for sexc,e
200 Ksh 199 10.6 1.0
200 Ksh 149 16.1 1.6 (0.9, 3.1)
Duration of prostitution (yr)
3 74 17.6 1.0f
3–5 145 16.6 0.9 (0.4, 2.0)
5 130 6.2 0.3 (0.1, 0.8)g
Avg no. of clients/wk
8 120 14.2 1.0
9–14 127 8.7 0.6 (0.3, 1.3)







Mgena (n  45)
Crude OR
(95% CI)b
Avg frequency of condom
usec
Half the time or less 92 4.4 1.0f,g
Most of the time 168 16.7 4.4 (1.5, 13.0)
Always 88 14.8 3.8 (1.2, 12.2)
Has a regular partner(s)
No 100 13.0 1.0
Yes 249 12.9 1.0 (0.5, 2.0)
Age at menarche (yr)
13 100 8.0 1.0f
14–15 147 14.3 1.9 (0.8, 4.5)
16 102 15.7 2.1 (0.9, 5.3)
Age at sexual debut (yr)
14 136 13.2 1.0
15–18 121 13.2 1.0 (0.5, 2.1)
19 92 12.0 0.9 (0.4, 2.0)
Age at parity (yr)
17 150 12.0 1.0
18–20 138 14.5 1.2 (0.6, 2.5)
21 61 11.5 1.0 (0.4, 2.4)
Depo/Norplant use
No 239 11.7 1.0
Yes 110 15.5 1.4 (0.7, 2.6)
Douche after sexc
No 85 10.6 1.0
Yes 177 14.1 1.4 (0.6, 3.1)
More than once per day 20 30.0 2.8 (0.9, 9.0)
Once per day or less 157 12.1 0.9 (0.4, 2.0)
Sex while in menses
No 271 15.5 1.0f,g
Yes 78 3.9 0.2 (0.1, 0.7)
Anal sexc
No 268 13.4 1.0f
Yes 80 11.3 0.2 (0.03, 1.7)
Lubricant use during sex
No 222 11.7 1.0f
Yes 127 15.0 0.8 (0.4, 1.4)
a Mgen, Mycoplasma genitalium.
b OR, odds ratio; 95% CI, 95% confidence intervals.
c Numbers do not add up to the total sample size due to missing data.
d The odds ratio represents a comparison between the categories “married/cohabiting”
and “widowed/divorced/separated” combined (collapsed due to sparse data) and the
referent “single/never married.”
e 4,000 Kenyan shillings (Ksh) is equivalent to $50 U.S.
f A P of 0.15 was selected for the multivariable logistic-regression model.
g P 0.05.
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among older women (P trends, 0.07 and 0.001, respectively).
However, age and HPV infection were positively correlated in that
women aged 35 years and older had a higher prevalence of infec-
tion than younger FSWs (P trend, 0.001). Women who had
worked in prostitution for less than 3 years had a high prevalence
of M. genitalium infection (17.6%), but infection decreased with
more years in prostitution (6.2%) (P trend, 0.01).
Independent correlates of Mycoplasma genitalium. The du-
ration of prostitution was negatively associated with M. genita-
lium; women who had worked in prostitution for 5 years were
less likely to be infected than women who had practiced it for 3
years (OR, 0.3; 95% CI, 0.1 to 0.8) (Table 2). Women who self-
reported using condoms most of the time or all the time were
more likely to have M. genitalium infection than those who self-
reported using condoms less frequently (OR, 4.4; 95% CI, 1.5 to
13.0; OR, 3.8; 95% CI, 1.2 to 12.2, respectively).
Participants who reported having sexual intercourse during
menses were less likely to have M. genitalium infection than those
who did not (OR, 0.2; 95% CI, 0.1 to 0.7). M. genitalium did not
appear to be associated with other STIs (N. gonorrhoeae tests were
not conducted due to insufficient sample size) or participant so-
ciodemographic characteristics (Table 2).
Multivariable analysis. Based on the univariable analyses,
variables selected for the multivariable model included age, dura-
tion of prostitution, average frequency of condom use, age at
menarche, sexual intercourse during menses, anal sex, income,
and use of a lubricant during sex (Table 3). Sex during menses
remained inversely associated with M. genitalium infection;
women who engaged in intercourse were less likely to have infec-
tion than those who did not (OR, 0.2; 95% CI, 0.1 to 0.8). FSW
who reported frequent condom use were more likely to be infected
with M. genitalium than women who reported using a condom
half the time or less (OR, 3.2; 95% CI, 1.0 to 9.8). M. genitalium
was less common among women who worked in prostitution for
5 years than in women who worked for 5 years (OR, 0.4; 95%
CI, 0.1 to 1.0).
M. genitalium and cervical cytology. The prevalence of M.
genitalium was highest in women with severely abnormal cytology
results (high-grade squamous intraepithelial lesion [HSIL] and
squamous cell carcinoma [SCC]) and atypical cytology results
(atypical cells of undetermined significance [ASCUS] and atypical
glandular cells of undetermined significance [AGUS]), at 20% and
21.4%, respectively. However, there was no evidence of an associ-
ation between M. genitalium infection and abnormal cytology
(OR, 1.1; 95% CI, 0.5 to 2.3), compared to the incidence of M.
genitalium infection in women with normal cytologies (Table 4).
DISCUSSION
The prevalence of M. genitalium in this population of FSWs was
12.9%, which is higher than the prevalences of C. trachomatis, N.
gonorrhoeae, and T. vaginalis. Compared to prevalences in other
studies in non-Westernized regions, the prevalence of M. genita-
lium infection was lower than in a population of FSWs in Kenya,
Ghana, and Benin (26%) but comparable to that of a high-risk
cohort in Japan (12.6%) (16, 18, 19). The variation in M. genita-
lium prevalences across studies may be due to differences in study
methods, such as the means of sampling of the source population,
user variation in specimen collection, and the detection assays
utilized. The age-specific prevalence of M. genitalium in this study
was comparable to that of other studies among female sex work-
ers, in whom the prevalence of M. genitalium generally decreased
as age increased (18, 23).
Women who reported using condoms with clients more than
50% of the time were more likely to be infected with M. genitalium
than women who reported less frequent condom use. These find-
ings are inconsistent with previous studies showing lower rates of
HIV/STI transmission among individuals with more frequent
condom use and may reflect potential overreporting of condom
use by study participants (41, 42). Comparatively, among female
sex workers in Ghana and Benin, women who reported using con-
doms with all clients had a lower prevalence of M. genitalium than
women who reported not using a condom with all clients (24%
versus 33%, P  0.02) (18). However, similar findings of a positive
association between M. genitalium prevalence and condom use
were observed in a study conducted among young men and
women attending an STI clinic (31). Social desirability bias may be
the cause of overreported condom use in the study; however, it







25–29 0.8 (0.3, 1.8)
30–34 0.5 (0.2, 1.4)
35 0.6 (0.2, 1.7)
Duration of prostitution (yr)
3 1.0
3–5 1.0 (0.4, 2.3)
5 0.4 (0.1, 1.0)
Income/moc
4,000 Ksh 1.0
4,000 Ksh 1.6 (0.8, 3.1)
Anal sex
No 1.0
Yes 0.3 (0.04, 2.7)
Sex during menses
No 1.0
Yes 0.2 (0.1, 0.8)d
Lubricant use during sex
No 1.0
Yes 0.6 (0.3, 1.2)
Age at menarche (yr)
13 1.0
14–15 1.7 (0.7, 4.3)
15 1.9 (0.7, 4.8)
Avg frequency of condom use
Half of the time or less 1.0
Most of the time 3.2 (1.0, 9.8)
Always 2.5 (0.8, 8.7)
a OR, odds ratio; 95% CI, 95% confidence intervals.
b Multivariable logistic-regression analyses, controlling for all other variables in table.
c 4,000 Ksh is equivalent to $50 U.S.
d P  0.05.
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merits further investigation of other mechanisms that may pro-
duce contradictory outcomes (43).
We also found that women who engaged in sexual intercourse
during menses were less likely to have M. genitalium infection
(OR, 0.2; 95% CI, 0.1 to 0.7), in contrast to previous research
which found that engaging in sexual intercourse during menses
increased the risk of STI, including chlamydia, genital herpes,
Trichomonas infection, and syphilis (44). Previous research has
shown a relationship between phases of the menstrual cycle and
M. genitalium infection; women in the proliferative phase (days 6
to 14) were more likely to have infection, but no women in the
menstrual phase (days 1 to 5) in the previous study were infected
with M. genitalium (9). This may suggest that a biological mech-
anism connected to the menstrual hormone cycle may have an
impact on becoming infected and/or on clearance of infection
with M. genitalium.
This study is the first to our knowledge to examine a wide
spectrum of potential correlates, including HPV infection and ab-
normal cervical lesions, in a population of female sex workers. The
prevalence of M. genitalium infection was higher among women
withseverelyabnormal(HSIL/SCC)andmildlyabnormal(ASCUS/
AGUS) cytologies, though there was no statistical evidence of an
association. However, M. genitalium may still have a contributory
role in the development of cervical neoplasia, via cervicitis and/or
HPV infection, as described in other studies (32). While the nat-
ural history of M. genitalium infection is not yet well understood,
it has been positively associated with cervical inflammation, a con-
dition associated with a higher risk of cervical neoplasia (9, 25, 33,
36, 37). This relationship warrants further investigation into the
prevalence and persistence of M. genitalium infection and cervical
outcomes.
This study has several strengths. Data for M. genitalium were
obtained using the Aptima Mgen laboratory assay, which employs
TMA-based methods (39). This diagnostic assay has been shown
to have a higher clinical sensitivity and specificity for M. genita-
lium detection than culture, which can be highly susceptible to
error due to improper specimen handling (45), and to have a
sensitivity and specificity for detection of M. genitalium similar to
those of PCR assays for M. genitalium detection (46). The inclu-
sion of HPV and abnormal cervical cytology in the analyses with
M. genitalium was another unique aspect of this study.
One limitation of our findings is the smaller sample size of the
population. As a result, the 95% confidence intervals of OR esti-
mates from analyses were relatively imprecise (confidence limit
ratio, 0.25) for several variables (47). Based on previous litera-
ture, we expected to observe associations between M. genitalium
and factors such as age, education, marital status, and sexual-
behavioral factors, including number of sexual partners/clients,
frequent douching, and hormone contraceptive use (16, 18, 22,
31). However, a larger study sample would likely improve our
power to detect correlations with M. genitalium and improve the
precision of the present findings. Our results were also limited by
the cross-sectional study design, as baseline data were assessed
from the collection of biological, sociodemographic, and sexual
behavioral data. Thus, we lacked the ability to establish temporal-
ity, and in the case of coinfections, we were unable to determine
whether a participant was infected with M. genitalium prior to
another pathogen and, consequently, whether the presence of one
infection impacted the presence of another infection. Addition-
ally, we collected data on sexual behaviors via self-reporting,
which is subject to recall and social desirability bias (43, 48). This
may have been the case with condom use frequency and other
reported sexual behaviors.
Overall, the results suggest that greater frequency of condom
use and duration of prostitution are associated with M. genitalium
infection. To further elucidate the correlates for M. genitalium,
longitudinal analyses might produce more-robust results, facili-
tating a better understanding of M. genitalium infection in rela-
tion to sexual behavior and other STIs. Targeted public health
interventions could then be directed to treating and preventing M.
genitalium and concomitant reproductive health complications in
populations with higher-risk women and low-resource settings.
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